There are various types of hepatic steatosis of which non-alcoholic fatty liver disease, which may be caused by exposure to chemicals and environmental pollutants is the most prevalent, representing a potential major health risk. QSAR modelling has the potential to provide a rapid and cost-effective method to identify compounds which may trigger steatosis. Although models exist to predict key molecular initiating events of steatosis such as nuclear receptor binding, we are aware of no models to predict the apical effect steatosis. In this study, we describe the development of a QSAR model to predict steatosis using freely available machine learning tools. It was built using a dataset of 207 pharmaceuticals and pesticides which were identifi...
In silico models are essential for the development of integrated alternative methods to identify org...
It is estimated that 1 in 3 people in the UK show early warning signs of Non-Alcoholic Fatty Liver D...
Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome and is t...
Nonalcoholic hepatic steatosis is a worldwide epidemiological concern since it is among the most pro...
Nonalcoholic hepatic steatosis is a worldwide epidemiological concern since it is among the most pro...
Nonalcoholic hepatic steatosis is a worldwide epidemiological concern since it is among the most pro...
A dataset comprising 55 chemicals with hepatocarcinogenic potency indices was collected from the Car...
A dataset comprising 55 chemicals with hepatocarcinogenic potency indices was collected from the Car...
Adverse effects of drugs (AEDs) continue to be a major cause of drug withdrawals in both development...
As one of the leading causes of drug failure in clinical trials, drug-induced liver injury (DILI) se...
Many animal models of non-alcoholic steatohepatitis have been reported. While these models exhibit m...
Adipose:blood partition coefficient is a key-input for models predicting the bioaccumulation and pha...
Α Quantitative Structure Activity Relationship (QSAR) model was developed in order to predict the ad...
In silico models are essential to the development of integrated alternative methods to identify orga...
Introduction: The data on human hepatotoxicity (drug-induced liver injury) is extremely important in...
In silico models are essential for the development of integrated alternative methods to identify org...
It is estimated that 1 in 3 people in the UK show early warning signs of Non-Alcoholic Fatty Liver D...
Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome and is t...
Nonalcoholic hepatic steatosis is a worldwide epidemiological concern since it is among the most pro...
Nonalcoholic hepatic steatosis is a worldwide epidemiological concern since it is among the most pro...
Nonalcoholic hepatic steatosis is a worldwide epidemiological concern since it is among the most pro...
A dataset comprising 55 chemicals with hepatocarcinogenic potency indices was collected from the Car...
A dataset comprising 55 chemicals with hepatocarcinogenic potency indices was collected from the Car...
Adverse effects of drugs (AEDs) continue to be a major cause of drug withdrawals in both development...
As one of the leading causes of drug failure in clinical trials, drug-induced liver injury (DILI) se...
Many animal models of non-alcoholic steatohepatitis have been reported. While these models exhibit m...
Adipose:blood partition coefficient is a key-input for models predicting the bioaccumulation and pha...
Α Quantitative Structure Activity Relationship (QSAR) model was developed in order to predict the ad...
In silico models are essential to the development of integrated alternative methods to identify orga...
Introduction: The data on human hepatotoxicity (drug-induced liver injury) is extremely important in...
In silico models are essential for the development of integrated alternative methods to identify org...
It is estimated that 1 in 3 people in the UK show early warning signs of Non-Alcoholic Fatty Liver D...
Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome and is t...